---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-076151"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-08-11T23:59:59+00:00"
generated_at: "2026-05-17T15:20:12.671215+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve asset sale to Ninjour Health and merger-related charter amendments

## Summary
- Asset Sale to Ninjour Health International Ltd approved: 1,273,715 For, 26,206 Against, 2,305 Abstentions.
- Charter amendment for Vyome Therapeutics merger approved: 1,240,191 For, 58,555 Against, 3,480 Abstentions.
- Special Meeting reconvened on August 7, 2025 after adjournment on July 24, 2025 to vote on these proposals.
- Amendments to Article VI of Restated Certificate of Incorporation will take effect at merger close.

## SEC filing metadata
- accession: 0001104659-25-076151
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-08-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925076151/0001104659-25-076151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925076151/tm2523158d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-076151
- JSON: https://secwatch.observer/filing/0001104659-25-076151.json
- Plain text: https://secwatch.observer/filing/0001104659-25-076151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.